Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novartis reports positive primary endpoint from the FIRST-STEP study of Stalevo

Jan. 28, 2008

First and only antiinflammatory pain relief patch available in the U.S.

Jan. 28, 2008

Combination of quetiapine and a mood stabilizer more effective in preventing mood episodes

Jan. 28, 2008

EMEA issues positive opinion of Cephalon's Effentora in breakthrough cancer pain

Jan. 25, 2008

Neurokinin 1 receptors linked to control of aggressiveness

Jan. 25, 2008

Sarcosine monotherapy assessed in schizophrenia patients

Jan. 25, 2008

Antidepressant-mGlu2/3 receptor agonist combination may improve depression

Jan. 25, 2008

FDA accepts NovaDel's NDA for ZolpiMist oral spray in the treatment of insomnia

Jan. 24, 2008

Johnson & Johnson submits NDA in U.S. for immediate release tapentadol

Jan. 24, 2008

FDA places clinical hold on CytRx's phase IIb clinical trial of arimoclomol for ALS

Jan. 24, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...